Mounjaro®
Starting from £179.99/mo
Start journey Learn moreOnce a Mounjaro KwikPen has been removed from the fridge and kept at room temperature, it should not be used after 30 days, regardless of how much medication remains in the pen. This 30-day window is set by Eli Lilly in the licensed product information and reflects stability data for tirzepatide outside refrigerated conditions. Using a pen beyond that point is not recommended, and the safest course is always to check the Mounjaro Summary of Product Characteristics on the Electronic Medicines Compendium (eMC) or speak to your prescriber if you are unsure. Mounjaro is a prescription-only medicine; clinical oversight matters at every stage of treatment, including how the pen is stored and when it is discarded.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The clock starts the moment the pen leaves the fridge. In refrigerated storage at 2–8°C, a Mounjaro KwikPen is stable until the printed expiry date on the label. Once you take it out, the medicine is exposed to room temperature, and from that point you have a maximum of 30 days before the pen must be discarded, used or not. This is not a conservative rounding of a longer figure; it is the licensed stability limit stated in the product information. There is a common assumption that, because a pen holds four doses, you have 28 days of injections and therefore a little buffer time. In practice, the 30-day window and the four-dose schedule overlap neatly if you start using the pen on or very close to the day you take it out of the fridge. Starting late erodes that margin. The full overview of how Mounjaro works covers the dosing schedule in context.
One thing worth letting go: the idea that a partially used pen with solution that still looks clear and colourless must be fine. Appearance alone does not confirm stability. The 30-day rule applies regardless.
If a pen has sat in the fridge since it was dispensed and has never been taken out, the printed expiry date is the relevant deadline, not 30 days from today. This matters if you have stockpiled pens or received a pen in advance of your next titration step. The practical question to ask yourself is honest and simple: when did this pen first leave the fridge? If you cannot recall with confidence, treating it as though the 30-day window has already been running from an uncertain date is the safer approach. For guidance on timing injections around meals and daily routines, separate storage and injection questions are answered in full.
Pens should not be frozen, should be kept away from direct sunlight, and should not be left in a hot car or near a heat source even within the 30-day window. Sub-optimal storage conditions at room temperature do not restart or pause the clock.
Discard it. A pen that has been out of the fridge for more than 30 days should not be injected, even if the scheduled dose day has not yet arrived. This can feel frustrating, particularly given the cost of private treatment, and it is one of the most practical reasons to keep track of dates when you first open a new pen. Writing the date on the barrel with a permanent marker the moment you take it from the fridge is a straightforward habit recommended by many prescribers. If you dispose of the pen, you will need a replacement before your next dose; speak to your prescribing team promptly rather than skipping a week without guidance. Disposal should be into a sharps container rather than household waste. The NHS patient information page for tirzepatide sets out the general storage and disposal guidance in plain language.
If you have missed a dose because a pen expired, if you are unsure whether to skip or delay a week, or if you are approaching a dose increase and a pen situation is creating confusion about timing, these are prescriber questions. Titration decisions belong in clinical hands. At nume, a GPhC-registered Independent Prescriber reviews every clinical query; the aftercare team is available seven days a week. Separately, if you are still working out whether this treatment is appropriate for your circumstances, the guidance on whether you can use Mounjaro covers the key eligibility and suitability questions in full. Questions about eligibility for starting treatment in the first place are also answered on the criteria for Mounjaro page. If cost or supply concerns are a factor in how you are managing pens, the honest breakdown of what Mounjaro costs privately in the UK may help you plan. For questions specific to starting treatment after a medical procedure, see the guidance on Mounjaro after surgery. If you are ready to speak with a prescriber, check your eligibility with our clinical team.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.